Correlation Between PDS Biotechnology and RYMAN HEALTHCAR

Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and RYMAN HEALTHCAR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and RYMAN HEALTHCAR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PDS Biotechnology Corp and RYMAN HEALTHCAR, you can compare the effects of market volatilities on PDS Biotechnology and RYMAN HEALTHCAR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of RYMAN HEALTHCAR. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and RYMAN HEALTHCAR.

Diversification Opportunities for PDS Biotechnology and RYMAN HEALTHCAR

0.73

Correlation Coefficient

PDS Biotechnology  RYMAN HEALTHCAR

Poor diversification

The 3 months correlation between PDS and RYMAN is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and RYMAN HEALTHCAR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RYMAN HEALTHCAR and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with RYMAN HEALTHCAR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RYMAN HEALTHCAR has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and RYMAN HEALTHCAR go up and down completely randomly.

Pair Corralation between PDS Biotechnology and RYMAN HEALTHCAR

Assuming the 90 days horizon PDS Biotechnology Corp is expected to under-perform the RYMAN HEALTHCAR. In addition to that, PDS Biotechnology is 3.75 times more volatile than RYMAN HEALTHCAR. It trades about -0.22 of its total potential returns per unit of risk. RYMAN HEALTHCAR is currently generating about -0.17 per unit of volatility. If you would invest  249.00  in RYMAN HEALTHCAR on October 25, 2024 and sell it today you would lose (8.00) from holding RYMAN HEALTHCAR or give up 3.21% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

PDS Biotechnology Corp  vs.  RYMAN HEALTHCAR

PDS Biotechnology Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

RYMAN HEALTHCAR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RYMAN HEALTHCAR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with PDS Biotechnology and RYMAN HEALTHCAR

The main advantage of trading using opposite PDS Biotechnology and RYMAN HEALTHCAR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, RYMAN HEALTHCAR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RYMAN HEALTHCAR will offset losses from the drop in RYMAN HEALTHCAR's long position.

The idea behind PDS Biotechnology Corp and RYMAN HEALTHCAR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.